title: When will French smokers be concerned by varenicline's benefit-to-risk ratio?
authors.affiliation: University Hospital, 80000 Amiens, France. Electronic address: braillon.alain@gmail.com.
authors.forename: Alain
authors.initials: A
authors.lastname: Braillon
mesh_terms: D006801:Humans; D018722:Nicotinic Agonists; D016017:Odds Ratio; D000074285:Smokers; D016540:Smoking Cessation; D000068580:Varenicline
chemical_list: D018722:Nicotinic Agonists; D000068580:Varenicline